Molecular regulators of defective placental and cardiovascular development in fetal growth restriction
Clinical Science · 03.07.2024 · 138 (13) · 761-775
DOI: 10.1042/cs20220428 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Science, online erschienen am 21.06.2024. Verfasst von Anandita Umapathy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Placenta. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council (NHMRC).
Abstract (Originalsprache)
Placental insufficiency is one of the major causes of fetal growth restriction (FGR), a significant pregnancy disorder in which the fetus fails to achieve its full growth potential in utero. As well as the acute consequences of being born too small, affected offspring are at increased risk of cardiovascular disease, diabetes and other chronic diseases in later life. The placenta and heart develop concurrently, therefore placental maldevelopment and function in FGR may have profound effect on the growth and differentiation of many organ systems, including the heart. Hence, understanding the key molecular players that are synergistically linked in the development of the placenta and heart is critical. This review highlights the key growth factors, angiogenic molecules and transcription factors that are common causes of defective placental and cardiovascular development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, New Zealand.
- Auckland Bioengineering Institute, Bioengineering Institute, New Zealand.
- Department of Paediatrics, Monash University, Melbourne, VIC, Australia and Monash Newborn, Monash Children's Hospital, Melbourne, VIC, Australia.
- Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne and Royal Women's Hospital, Victoria, Australia.
- First year college, Victoria University, St Albans, Victoria 3021, Australia.
- Department of Maternal Fetal Medicine, Pregnancy Research Centre, Royal Women's Hospital, Victoria, Australia.
ORCID-Profile: Padma Murthi
Förderung
- National Health and Medical Research Council (NHMRC)
Zitieren
APA
Umapathy, A., Clark, A., Sehgal, A., Karanam, V., Rajaraman, G., Kalionis, B., Jones, H. N., James, J., & Murthi, P. (2024). Molecular regulators of defective placental and cardiovascular development in fetal growth restriction. Clinical Science, 138(13), 761-775. https://doi.org/10.1042/cs20220428
Vancouver
Umapathy A, Clark A, Sehgal A, Karanam V, Rajaraman G, Kalionis B, et al. Molecular regulators of defective placental and cardiovascular development in fetal growth restriction. Clinical Science. 2024;138(13):761-775. doi:10.1042/cs20220428
BibTeX
@article{Umapathy2024,
author = {Umapathy, Anandita and Clark, Alys and Sehgal, Arvind and Karanam, Vijaya and Rajaraman, Gayathri and Kalionis, Bill and Jones, Helen N and James, Jo and Murthi, Padma},
title = {Molecular regulators of defective placental and cardiovascular development in fetal growth restriction},
journal = {Clinical Science},
year = {2024},
volume = {138},
number = {13},
pages = {761--775},
doi = {10.1042/cs20220428}
}
EUVIMED